Emcure Pharmaceuticals Q2 Results
- BSE: 544210
- NSE: EMCURE
- ISIN: INE168P01015
- Sector: -
BSE
1,318.35
-20.15 (-1.51%)
-20.15 (-1.51%)Volume1.51 K
Updated: Thu 19 Jun, 2025 | 15:28:00
NSE
1,325.50-13.40 (-1.00%)
-13.40 (-1.00%)Volume1.43 L
Updated: Thu 19 Jun, 2025 | 15:40:14
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Emcure Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 2,001.98 | 1,815.14 | 10.29% | 2,001.98 | N/A |
| Selling/ General/ Admin Expenses Total | 355.59 | 350.40 | 1.48% | 355.59 | N/A |
| Depreciation/ Amortization | 96.90 | 93.59 | 3.53% | 96.90 | N/A |
| Other Operating Expenses Total | 476.85 | 445.32 | 7.08% | 476.85 | N/A |
| Total Operating Expense | 1,718.01 | 1,572.41 | 9.26% | 1,718.01 | N/A |
| Operating Income | 283.98 | 242.73 | 16.99% | 283.98 | N/A |
| Net Income Before Taxes | 273.41 | 207.41 | 31.82% | 273.41 | N/A |
| Net Income | 194.57 | 144.08 | 35.04% | 194.57 | N/A |
| Diluted Normalized EPS | 10.33 | 7.95 | 29.94% | 10.33 | N/A |